University of California San Francisco
Give to UCSFAn experimental adaptive deep brain stimulation (aDBS) device had tremendous success in a trial that helped a Parkinson’s patient, who is a former skateboarding professional, resume skating and mentoring San Francisco youth.
A UCSF-created child-parent therapy for trauma in kids under age 5 was found to slow down biological aging, which is tied to health benefits later in life.
A breakthrough study shows how a ketogenic diet alters human metabolism and makes a particular pancreatic cancer drug effective by starving tumors of fat that they feed on to grow.
UCSF received its first philanthropic grant for workforce training and development. The $14M gift from Crankstart will train workers as medical assistants, radiology technologists, and practice coordinators; support training programs by outside partners; and establish an internal program to help connect them with jobs at UCSF Health and campus research projects.
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
A study found that states with more comprehensive mental and behavioral health insurance policies and enforcement of those policies allows caregivers easier access to care for their children.
Aashish Manglik delivered the 29th annual Byers Award Lecture titled “Signal Reception: Cracking Codes in Cellular Communication.”
Patients sent about the same number of emails to clinicians after UC San Francisco’s health system, UCSF Health, began charging for certain types of messages, a new study found. In line with
Scientists at UCSF discovered how kids were developing multisystem inflammatory syndrome in children (MIS-C), a mysterious, life-threatening condition following a COVID infection.
Radiation from X-rays is an occupational hazard for many medical specialists, including cardiologists, vascular and orthopedic surgeons, urologists, some radiologists and gastroenterologists.
Scientists at UCSF and Contineum Therapeutics have developed a drug that spurs the body to replace the protective insulation around nerve cells, myelin, that is lost in multiple sclerosis. If it works in people, it could be a way to reverse the damage caused by the disease.